Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

We examined the feasibility and safety of using paclitaxel and trastuzumab as maintenance therapy after high-dose chemotherapy (HDC) with autologous hematopoietic stem cell transplantation (AHST) for patients with HER2-positive metastatic breast cancer. Ten patients (9 women and 1 man) were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yee Chung, Rondón, Gabriela, Anderlini, Paolo, Khouri, Issa F., Champlin, Richard E., Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805996/
https://www.ncbi.nlm.nih.gov/pubmed/24155780
http://dx.doi.org/10.7150/jca.6775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805996/
https://www.ncbi.nlm.nih.gov/pubmed/24155780
http://dx.doi.org/10.7150/jca.6775

Ejemplares similares